OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review
Zou Xiang, Xi-Yu Tang, Zhongyuan Qu, et al.
International Journal of Biological Macromolecules (2022) Vol. 202, pp. 539-557
Closed Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Zhenling Liu, Huanhuan Chen, Lili Zheng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 381

A Positive Feedback Loop between Inactive VHL-Triggered Histone Lactylation and PDGFRβ Signaling Drives Clear Cell Renal Cell Carcinoma Progression
Jiefeng Yang, Li Luo, Chongyu Zhao, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 8, pp. 3470-3483
Open Access | Times Cited: 100

A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions
Selvaraj Vimalraj
International Journal of Biological Macromolecules (2022) Vol. 221, pp. 1428-1438
Closed Access | Times Cited: 83

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80

New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies
Pratibha Pandey, Fahad Khan, Tarun Kumar Upadhyay, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114491-114491
Open Access | Times Cited: 60

Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies
Changyu Yao, Shilun Wu, Jian Kong, et al.
Cancer Biology and Medicine (2023) Vol. 20, Iss. 1, pp. 25-43
Open Access | Times Cited: 55

Targeting the tumor microenvironment: Potential strategy for cancer therapeutics
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166746-166746
Open Access | Times Cited: 40

Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 23

Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets
Zhaoliang Hu, Xushi Zhao, Zhonghua Wu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19

A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update
Anuja Gajanan Magar, Vivek Kumar Morya, Mi Kyung Kwak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3313-3313
Open Access | Times Cited: 16

Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications
Chiara Puricelli, Elena Boggio, Casimiro Luca Gigliotti, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4565-4565
Open Access | Times Cited: 20

Anti‐angiogenesis in colorectal cancer therapy
Zhenni Yang, Xuqian Zhang, Xiaozhe Bai, et al.
Cancer Science (2024) Vol. 115, Iss. 3, pp. 734-751
Open Access | Times Cited: 10

Inhibition of cancer cells by Quinoline-Based compounds: A review with mechanistic insights
Anjali Saxena, Suman Majee, Devalina Ray, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117681-117681
Closed Access | Times Cited: 10

Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma
Mohammad Habeeb, Hariharan Thirumalai Vengateswaran, Huay Woon You, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 7, pp. 1677-1705
Closed Access | Times Cited: 8

Current status of drugs targeting PDGF/PDGFR
Jing-Yan Ai, Chenfu Liu, Wen Zhang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 103989-103989
Closed Access | Times Cited: 7

Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access

Decoding oral cancer: insights from miRNA expression profiles and their regulatory targets
Xin Wang, Shuang Zhang, Shuyi Wang, et al.
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access

The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy
Kaili Liao, Xue Zhang, Jie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 17

New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis
Xin Li, Jianbo Zhou, Xue Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114806-114806
Open Access | Times Cited: 16

Cancer-Associated Fibroblasts Promote Lymphatic Metastasis in Cholangiocarcinoma via the PDGF-BB/PDGFR-β Mediated Paracrine Signaling Network
Jian Yan, Gang Xiao, Caini Yang, et al.
Aging and Disease (2023) Vol. 15, Iss. 1, pp. 369-369
Open Access | Times Cited: 14

EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 4

Dysregulations of Key Regulators of Angiogenesis and Inflammation in Abdominal Aortic Aneurysm
Daniel Zalewski, Paulina Chmiel, Przemysław Kołodziej, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12087-12087
Open Access | Times Cited: 13

MOLECULAR DOCKING AND INVESTIGATION OF BOSWELLIA SERRATA PHYTOCOMPOUNDS AS CANCER THERAPEUTICS TO TARGET GROWTH FACTOR RECEPTORS: AN IN SILICO APPROACH
B. R. JAYASURYA, J. S. SWATHY, Susha Dinesh, et al.
International Journal of Applied Pharmaceutics (2023), pp. 173-183
Open Access | Times Cited: 11

Page 1 - Next Page

Scroll to top